Ataş, M. Et Al. 2023. Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema. European Journal of Ophthalmology , vol.33, no.2 , 1132-1139.

Ataş, M., Ozsaygılı, C., Bayram, N., & Unal, S., (2023). Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema. European Journal of Ophthalmology , vol.33, no.2, 1132-1139.

Ataş, Mustafa Et Al. "Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema," European Journal of Ophthalmology , vol.33, no.2, 1132-1139, 2023

Ataş, Mustafa Et Al. "Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema." European Journal of Ophthalmology , vol.33, no.2, pp.1132-1139, 2023

Ataş, M. Et Al. (2023) . "Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema." European Journal of Ophthalmology , vol.33, no.2, pp.1132-1139.

@article{article, author={Mustafa Ataş Et Al. }, title={Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema}, journal={European Journal of Ophthalmology}, year=2023, pages={1132-1139} }